Evolent Health, Inc.
As of Oct 23, 2026 close
- Market cap
- $540.20M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $2.10$8.30
- Volume (live)
- -
- Avg. volume (3M)
- 1.87M
Evolent Health (EVH) Stock Price & Financial Analysis
Evolent Health Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $4.76 - $4.95 |
|---|---|
| 52-Week High | $8.30 |
| 52-Week Low | $2.10 |
| Open | $4.86 |
| Volume (last close) | 1.23M |
| Average Volume (3M) | 1.87M |
| Revenue (TTM) | 2.10B |
|---|---|
| Net Income (TTM) | -504.99M |
| Free Cash Flow (TTM) | 24.34M |
| EPS (TTM) | −$4.46 |
| Profit Margin | -24.08% |
| Operating Margin | -1.47% |
| Return on Equity (ROE) | -131.77% |
| Debt to Equity | 2.53 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 540.20M |
|---|---|
| Shares Outstanding | 112.54M |
| Price to Sales (P/S) | 0.26 |
| Price to Book (P/B) | 1.41 |
| EV/EBITDA | -4.27 |
| 50-Day MA | $4.19 |
|---|---|
| 200-Day MA | $3.85 |
| 1-Year Change | −34.80% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Evolent Health at a Glance
As of the Oct 23, 2026 close, Evolent Health (EVH) has a market capitalization of $540.20M. The stock trades at 0.3× sales. Over the trailing twelve months it lost $504.99M on revenue of $2.10B and generated $24.34M of free cash flow. Revenue fell 4.5% year over year.
As of its latest reported balance sheet, it holds $115.70M in cash and securities against $968.01M of debt, a net debt position of $852.30M.
Evolent Health does not currently pay a dividend.
The share price is down 34.8% over the past year. At $4.80 (the Oct 23, 2026 close) it sits within its 52-week range of $2.10 to $8.30, above its 200-day moving average of $3.85.
Based on 13 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $5.56, 15.8% above the Oct 23, 2026 close.
Frequently Asked Questions About Evolent Health
What is the current stock price for EVH?
As of the Oct 23, 2026 close, EVH stock trades at $4.80. The 52-week range is $2.10–$8.30, with a day range of $4.75–$4.95.
What is the P/E ratio for EVH?
The P/E ratio (Price-to-Earnings) for EVH is shown in the Key Statistics section. This valuation metric helps compare Evolent Health, Inc. to industry peers.
Does EVH pay dividends?
Evolent Health does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for EVH?
Based on ratings from 13 professional analysts over the last 90 days, the consensus for EVH is Buy. The average 12-month price target is $5.56, a 15.8% upside from the Oct 23, 2026 close of $4.80.
What is the market cap of EVH?
As of the Oct 23, 2026 close, Evolent Health's market capitalization is $540.2M, classifying it as a small-cap company. Evolent Health operates in the Healthcare sector within the Health Information Services industry.